Question explored with the scientific record
Are people not undertsanding what they put in vaccines? Pig cells monkey kidney cells HEAVY METALS like mercury and aborted fetus cells. All this is some shaytan crap that will mess your body up and cells
The short version: the evidence shows real biological risks from thimerosal's mercury and from manufacturing residues, but the question lumps together very different things—some are proven hazards, some are trace contaminants with no demonstrated harm.
Let me separate them. Thimerosal is the strongest concern. It is an organic mercury compound that breaks down into ethylmercury, a known neurotoxin. A 2018 study using Vaccine Safety Datalink records found a dose-dependent link between thimerosal-containing hepatitis B vaccines given in the first six months of life and later premature puberty diagnosis, with odds ratios around 1.8 to 2.1 depending on dose [10]. A 2013 study found a similar association with autism spectrum disorder: children exposed to 37.5 micrograms of mercury from vaccines had 3.4 times the odds of an ASD diagnosis compared to unexposed children [13]. A 2020 Science paper showed that thimerosal and its breakdown product ethylmercury bind to dopamine receptors in the brain at nanomolar concentrations—levels that match estimated brain mercury from infant vaccination [17]. That is not an inert preservative. That is a biologically active compound hitting targets in the central nervous system.
The animal-cell and fetal-cell concerns are different. Pig cells, monkey kidney cells, and fetal cell lines (like HEK-293, derived from an aborted fetus in 1973) are used to grow viruses for vaccine production, then the viruses are purified away from those cells. The final vaccine contains trace protein residues, not whole cells. A 2011 study showed MDCK dog kidney cells can produce influenza vaccine in serum-free conditions with standard purification steps [9]. A 1986 study used Vero monkey kidney cells for rabies vaccine with 100% survival in 106 exposed patients [4]. The question is whether residual DNA or protein from these cell lines causes harm. The evidence does not show that it does. The Catholic Church has issued guidance saying use of these vaccines is morally permissible when no alternative exists [21]. That is not a safety endorsement, but it reflects that the cells themselves are not in the final product.
The "heavy metals" claim is mostly about thimerosal, which has been removed from most childhood vaccines in the US since 2002—except some flu shots. Aluminum adjuvants are a separate concern not addressed by this evidence.
| Ingredient | Evidence of harm | What the evidence shows |
|---|---|---|
| Thimerosal (ethylmercury) | Strong | Dose-dependent links to premature puberty [10] and autism [13]; binds dopamine receptors at brain-relevant concentrations [17] |
| Fetal cell lines (HEK-293, Per.C6) | None shown | Used to grow viruses; purified away; no evidence of residual harm in final product |
| Animal cells (Vero, MDCK) | None shown | Used in licensed rabies [4] and influenza [9] vaccines; standard purification removes cells |
My call: thimerosal is a genuine concern with published epidemiological and mechanistic evidence of harm, and its removal from most childhood vaccines was justified. The animal-cell and fetal-cell residues are manufacturing artifacts that the evidence does not show cause harm. Confidence: moderate for thimerosal (multiple studies, but all observational); low for cell-line residues (no evidence of harm, but also no long-term safety studies comparing purified vs unpurified vaccines).
Sources examined 29
-
Recombinant mutagenic 3ABC protein and monoclonal antibody for quality-control testing in foot-and-mouth disease vaccines
The study engineered a mutagenic recombinant 3ABC nonstructural protein from foot-and-mouth disease virus (FMDV), produced monoclonal antibodies against it, and demonstrated their potential as a quality-control reagent to detect NSP 3ABC and distinguish infected from vaccinated …
DOI: 10.1016/j.antiviral.2018.07.002 -
Rapid COVID-19 vaccine development
Urgent call for rapid COVID-19 vaccine development that prioritizes safety by avoiding vaccine-enhanced disease through conformationally correct spike antigens and robust neutralizing antibody responses validated in preclinical models and early trials.
DOI: 10.1126/science.abb8923 -
Binding and cleavage (BINACLE) assay for the functional in vitro detection of tetanus toxin: Applicability as alternative method for the safety testing of tetanus toxoids during vaccine production
This study presents the BINACLE in vitro assay (binding and cleavage) for detecting active tetanus toxin in toxoids, showing sensitivity comparable to animal tests in buffer and demonstrating manufacturer-specific performance with toxoids, suggesting potential as an animal-free …
DOI: 10.1016/j.vaccine.2013.10.028 -
NEW PURIFIED VERO-CELL VACCINE PREVENTS RABIES IN PATIENTS BITTEN BY RABID ANIMALS
A clinical study evaluating the purified vero-cell rabies vaccine (PVRV) for post-exposure prophylaxis in 106 rabies-exposed patients, demonstrating 100% survival at 1 year, durable neutralizing antibody responses, minimal side effects, and potential cost advantages over traditi…
DOI: 10.1016/s0140-6736(86)91946-x -
Bridging the Gap Between Validation and Implementation of Non-Animal Veterinary Vaccine Potency Testing Methods
A bridging paradigm successfully expanded implementation of non-animal veterinary vaccine potency testing methods by systematically addressing regulatory and industrial barriers.
DOI: 10.3390/ani1040414 -
Portable, On-Demand Biomolecular Manufacturing
This study presents a cell-free platform for on-site, on-demand biomolecular manufacturing, demonstrating the synthesis and functional validation of antimicrobial peptides and vaccines, as well as combinatorial manufacturing of antibody mimetic conjugates and small molecules.
DOI: 10.1016/j.cell.2016.09.013 -
Investigating the impact of oxygen concentration on the assembly of human papillomavirus virus like particles
The study demonstrates that increasing oxygen concentration during the assembly of HPV L1 pentamers into virus-like particles accelerates assembly, elevates disulfide bond formation, and markedly enhances antigen potency across multiple HPV types, with validation at two producti…
DOI: 10.1038/s41598-025-30597-y -
Replacement of in vivo human rabies vaccine potency testing by in vitro glycoprotein quantification using ELISA – Results of an international collaborative study
This study evaluates three different ELISA methods as in vitro alternatives to the NIH in vivo potency test for human rabies vaccines, demonstrating their ability to discriminate between potent and sub-potent vaccine batches.
DOI: 10.1016/j.vaccine.2016.12.039 -
Production of Inactivated Influenza H5N1 Vaccines from MDCK Cells in Serum-Free Medium
This study develops a high-yield, serum-free MDCK-cell–based manufacturing process for influenza A(H5N1) vaccines, demonstrating scalable production in microcarrier bioreactors with comparable antigenicity and mouse-immunogenicity to serum-containing methods and lower-cost opera…
DOI: 10.1371/journal.pone.0014578 -
Premature Puberty and Thimerosal-Containing Hepatitis B Vaccination: A Case-Control Study in the Vaccine Safety Datalink
A longitudinal case-control study using Vaccine Safety Datalink data finds a dose-dependent association between organic mercury exposure from Thimerosal-containing hepatitis B vaccines given in the first six months of life and the long-term risk of a premature puberty diagnosis,…
DOI: 10.3390/toxics6040067 -
Comparison of Blood and Brain Mercury Levels in Infant Monkeys Exposed to Methylmercury or Vaccines Containing Thimerosal
This study directly compared the blood and brain disposition of mercury in infant Macaca fascicularis after exposure to methylmercury or vaccines containing thimerosal, finding faster systemic clearance and markedly lower brain mercury with thimerosal and concluding that methylm…
DOI: 10.1289/ehp.7712 -
An Evaluation of the Effects of Thimerosal on Neurodevelopmental Disorders Reported Following DTP and Hib Vaccines in Comparison to DTPH Vaccine in the United States
Using VAERS data, this study reports associations between thimerosal-containing DTP vaccines and increased risk of multiple neurodevelopmental disorders in U.S. children compared with thimerosal-free DTPH vaccines.
DOI: 10.1080/15287390500364556 -
A two-phase study evaluating the relationship between Thimerosal-containing vaccine administration and the risk for an autism spectrum disorder diagnosis in the United States
This study investigates the potential link between Thimerosal-containing vaccines and the risk of autism spectrum disorder (ASD) through a two-phase analysis of vaccine safety data, revealing a significant association between organic mercury exposure from these vaccines and ASD …
DOI: 10.1186/2047-9158-2-25 -
Apparent vaccine-thimerosal induced hypersensitivity, myelodysplastic syndrome and pancytopenia
A single-patient case report describing rapid hypersensitivity reaction, myelodysplastic syndrome and pancytopenia following a thimerosal-containing tetanus vaccine, with subsequent recovery and discussion of mercury toxicity risk.
DOI: 10.3855/jidc.378 -
Vaccines are not associated with autism: An evidence-based meta-analysis of case-control and cohort studies
This meta-analysis of case-control and cohort studies found no evidence to support a link between childhood vaccinations and the development of autism or autism spectrum disorders.
DOI: 10.1016/j.vaccine.2014.04.085 -
Neurotoxic character of thimerosal and the allometric extrapolation of adult clearance half‐time to infants
This study investigates the neurotoxic effects of thimerosal, an organomercurial compound used as a vaccine preservative, and extrapolates the clearance half-time of ethylmercury in adults to infants, revealing that infants may clear mercury more efficiently than previously thou…
DOI: 10.1002/jat.918 -
The activities of drug inactive ingredients on biological targets
A focused, proof-of-concept study showing that many FDA-approved inactive pharmaceutical excipients can directly bind to and modulate biologically relevant targets in vitro and that systemic exposure in some cases could reach concentrations capable of target engagement, challeng…
DOI: 10.1126/science.aaz9906 -
Detection of Antinuclear and Antilaminin Antibodies in Autistic Children Who Received Thimerosal-Containing Vaccines
This study investigates the presence of mercury-induced antinuclear and antilaminin antibodies in autistic children who received thimerosal-containing vaccines, finding no significant differences in antibody levels compared to normal children, suggesting that thimerosal is likel…
DOI: 10.1159/000079672 -
Thimerosal Exposure and the Role of Sulfation Chemistry and Thiol Availability in Autism
A critical review arguing that limited thiol availability and abnormal sulfation in some children with autism increase susceptibility to thimerosal in vaccines, supporting removal of thimerosal from vaccines based on mechanistic and indirect evidence across in vitro, in vivo, an…
DOI: 10.3390/ijerph10083771 -
Thimerosal distribution and metabolism in neonatal mice: comparison with methyl mercury
This study compares the distribution and metabolism of thimerosal and methyl mercury in neonatal mice, revealing significant differences in tissue concentrations and kinetics that challenge the assumption of their toxicological equivalence.
DOI: 10.1002/jat.1272 -
Szczepionka przeciw wirusowi SARS CoV-2. Zagadnienia etycznomoralne
Ethical and theological exploration of SARS-CoV-2 vaccination, addressing mRNA vaccine technology, use of fetal cell lines, and Catholic Church guidance on voluntary vaccination and public health during the COVID-19 pandemic.
DOI: 10.31261/ssht.2022.55.1.05 -
Preexisting vaccine-primed heterosubtypic T cell immunity protects the maternal-fetal unit from adverse influenza outcomes in mice
This study demonstrates that preexisting vaccine-primed heterosubtypic T cell immunity can protect the maternal-fetal unit from severe outcomes of influenza infection during pregnancy in mice.
DOI: 10.1172/JCI179230 -
Selective knockout of key CMV receptors in fetal cells blocks direct and endocytic pathways of entry in the guinea pig
In a guinea pig cytomegalovirus model, the study uses CRISPR/Cas9 to knock out direct-entry receptor PDGFRA and endocytic-entry candidates NRP2 or CD147 in guinea pig fetal fibroblast cells, demonstrating that dual PDGFRA+NRP2 knockout blocks both direct and endocytic GPCMV entr…
DOI: 10.1101/2025.08.05.668711 -
Fetal public Vγ9Vδ2 T cells expand and gain potent cytotoxic functions early after birth
This study shows that human fetal-derived public Vγ9Vδ2 T cells expand within the first 10 weeks after birth, differentiate into potent cytotoxic effector cells largely independent of newborn BCG vaccination, and retain a fetal-origin TCR repertoire with substantial early-life f…
DOI: 10.1073/pnas.1922595117 -
Propagation of Human Hepatitis A Virus in Cell Culture in Vitro
This study successfully propagated the human hepatitis A virus in vitro using liver explant cultures from marmosets and a fetal rhesus kidney cell line, establishing methods for future vaccine and diagnostic antigen production.
DOI: 10.3181/00379727-160-40422 -
Synergistic teratogenic effect produced in mice by whole cell pertussis vaccine
This study investigates the teratogenic effects of the whole cell pertussis vaccine in pregnant mice, revealing a synergistic interaction with cytochalasin D that leads to significant brain malformations in fetuses, while identifying lipopolysaccharides as potential teratogenic …
DOI: 10.1016/0264-410x(87)90103-4 -
Ultraviolet-C irradiation for inactivation of viruses in foetal bovine serum
This study evaluates a spiral-flow UV-C irradiation system (UVivatec) for inactivating a panel of live attenuated and other model viruses spiked into fetal bovine serum (FBS) and cell culture media, assesses the impact on media growth properties using fastidious MRC-5 cells, and…
DOI: 10.1016/j.vaccine.2018.06.008 -
Immunity to Cytomegalovirus in Early Life
A narrative review that synthesizes current knowledge of innate and adaptive immunity to cytomegalovirus (CMV) in fetal life and infancy, highlighting CMV-induced fetal γδ T cell and NK cell responses, dendritic cell function, and CMV-specific T and B cell dynamics, and discussi…
DOI: 10.3389/fimmu.2014.00552 -
A vaccine against cytomegalovirus: how close are we?
A comprehensive review of human cytomegalovirus (CMV) vaccine development, detailing immunologic targets (gB, pentameric complex, T cell epitopes), various vaccine platforms (subunit, DNA, MVA, VLP, mRNA, DISC), and the status/outcomes of clinical trials aimed at preventing cong…
DOI: 10.1172/jci182317